Project Grant K99AG086609

Award Date 4/15/24
Completion Date 3/31/26
Dollars Obligated $385K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $258,498.00 to the University of California, Los Angeles (UCLA) to investigate the biological pathways linking sleep health to Alzheimer's disease and cognitive decline. The key objectives are to: Use a multi-omics approach to analyze methylation and metabolomics data associated with short sleep and insomnia among a high-risk Hispanic population, and compare the results to Alzheimer's...
This $1,955,041 Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), will fund research into the relationship between sleep, pericytes, and Alzheimer's disease pathology. The Medical University of South Carolina will investigate whether pericytes, cells that regulate cerebral blood flow and blood-brain barrier permeability, mediate the effects of sleep disruption on Alzheimer's disease progression. Specifically, the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,498,158 to Synaptic Health LLC to develop a novel closed-loop feedback neuromodulation system to improve slow wave sleep in Alzheimer's disease patients. The goal of this Phase I project is to create a testable prototype that can sense sleep architecture and provide peripheral neuromodulation stimulation to individuals over 65, a high-risk group for Alzheimer's disease. Successful...
This Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research into the molecular interplay of sleep and neurodegeneration using the Drosophila model system. With $2.14 million provided over 11 months, the Trustees of the University of Pennsylvania will investigate how expression of the TDP-43 protein linked to neurodegenerative diseases disrupts sleep in fruit flies. Researchers will aim to define the specific glial subtypes...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), is focused on assessing whether genetic risk variants for Alzheimer's disease (AD) have a pleiotropic effect on sleep. The primary objectives are to conduct in silico variant-to-gene mapping analysis to identify potential shared genetic factors underlying AD and sleep phenotypes, and to use CRISPR in zebrafish models to directly evaluate the impact of putative AD...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $383,400 to Dr. Minjee Kim at Northwestern University to investigate the role of sleep disturbance as a potentially modifiable determinant of cognitive impairment and Alzheimer's disease. The award will fund Dr. Kim's research to: 1) examine associations between sleep disturbance, cognitive function, self-care capacity, and health status in middle-aged adults; 2) develop sleep disturbance...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to investigate memory reactivation during sleep in a mouse model of Alzheimer's disease (AD). The $132,705 award, spanning from September 1, 2024 to August 31, 2026, will enable the Icahn School of Medicine at Mount Sinai to use two-photon microscopy and electrophysiology to measure brain activity across wake and sleep states in AD model mice. The research aims to determine if...
The National Institute on Aging (NIA) awarded Brigham & Women's Hospital Inc. a $2,576,936 Project Grant under the Aging Research federal grant program (CFDA 93.866) to characterize the variability in sleep spindle activity across a population and evaluate the use of sleep spindle dynamics as biomarkers for Alzheimer's disease, mild cognitive impairment, and trisomy 21. The 3-year project will develop statistical models and methods to analyze sleep spindle patterns and their relationship...
This federal Project Grant award of $442,938, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports research at the University of California, San Francisco (UCSF) to investigate the relationship between sleep, memory, and aging. The key objectives are to: 1) characterize how aging affects sleep patterns required for memory consolidation and synaptic plasticity during long-term memory formation; and 2) determine how upregulating the unfolded protein response can...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $684,924 to Northwestern University to conduct research on the relationship between the noradrenergic (NA) system, sleep quality, and cognitive function in older adults with insomnia. The project aims to systematically characterize central and peripheral measures of the NA system and assess their association with sleep quality and cognitive performance in older adults with insomnia, as well as...

CONTRIBUTION OF HYPOCRETIN NEURON ACTIVITY TO ALZHEIMER'S RELATED SLEEP DISTURBANCES - PROJECT SUMMARY SLEEP IS A VERY WELL CONSERVED BEHAVIORAL STATE ACROSS ALL ANIMALS. THOUGH THE EXACT FUNCTION OF SLEEP REMAINS UNKNOWN, IT IS WIDELY APPRECIATED THAT GOOD SLEEP QUALITY IS A CORNERSTONE FOR ANY HEALTHY ORGANISM. INDEED, SEVERAL NEUROLOGICAL DISORDERS ARE CO-MORBID WITH SLEEP DISTURBANCES. FURTHERMORE, ALTERED SLEEP AS OBSERVED IN SLEEP APNEA, INSOMNIA OR SLEEP DEPRIVATION SHOW IMPAIRMENTS IN MEMORY CONSOLIDATION AND INCREASED RISK FOR DEPRESSION, CANCER, ALZHEIMER'S DISEASE (AD), AND OTHER NEUROPSYCHIATRIC DISORDERS. AD PATIENTS HAVE BEEN SHOWN TO DISPLAY ALTERED SLEEP ARCHITECTURE. SLEEP PLAYS A ROLE IN CLEARANCE OF BETA-AMYLOID (AB) IN INTERSTITIAL SPACE. EXCESSIVE ACCUMULATION OF AB, A PROMINENT FEATURE OF AD, HAS BEEN SHOWN TO ALTER SLEEP. RECENT WORK IN OUR LAB HAS DEMONSTRATED THAT HYPEREXCITABILITY OF WAKE-PROMOTING HYPOCRETIN (HCRT) NEURONS OF THE LATERAL HYPOTHALAMUS (LH), RESULTING FROM NATURAL AGING, MAY UNDERLIE INCREASED SLEEP FRAGMENTATION DURING AGING. IT IS LIKELY THAT THESE SAME NEURONS MAY HAVE ALTERED EXCITABILITY IN AD, EXACERBATED BY THE PRESENCE OF AB ACCUMULATION, AND MAY DRIVE SLEEP FRAGMENTATION AND SLEEP DISTURBANCES OBSERVED IN AD PATIENTS. THE OVERARCHING AIM OF THIS PROPOSAL IS TO UNDERSTAND HOW AB ACCUMULATION IMPACTS HYPOCRETIN NEURON ACTIVITY LEADING TO ALTERED HOMEOSTATIC SLEEP PRESSURE AND SUBSEQUENT DISRUPTED SLEEP ARCHITECTURE OBSERVED IN ALZHEIMER'S DISEASE. THE CENTRAL HYPOTHESIS IS THAT ACCUMULATION OF AB ACCELERATES NATURAL HCRT NEURON DEATH LEADING TO HYPEREXCITABILITY OF SURVIVING HCRT NEURONS AND DISRUPTED SLEEP PRESSURE AND ARCHITECTURE. THIS PROPOSAL FOCUSES ON HCRT NEURONS AS THEY HAVE BEEN SUGGESTED TO BE AN INTEGRATION HUB WHICH CONSOLIDATES SEVERAL STREAMS OF INPUT AND SENDS SIGNALS TO DOWNSTREAM AROUSAL-PROMOTING REGIONS. TO UNDERSTAND THIS INTERACTION, I WILL FIRST NEED TO DEMONSTRATE ALTERED HCRT NEURON ACTIVITY IN THE PRESENCE OF AB ACCUMULATION, ITS IMPACT ON SLEEP (AIM 1), AND DEMONSTRATE CHANGES TO THE INTRINSIC AND SYNAPTIC EXCITABILITY OF HCRT NEURONS (AIM 2). FINALLY, I WILL CONSOLIDATE THE FINDINGS INTO A BIOPHYSICALLY REALISTIC COMPUTATIONAL NETWORK MODEL WITH SLEEP-WAKE TRANSITIONS TO MAKE VIABLE PREDICTIONS ABOUT THE RELATIVE CONTRIBUTIONS OF VARIOUS IONIC / SYNAPTIC CURRENTS TO CHANGES IN INTRINSIC HCRT NEURON ACTIVITY AND ITS IMPACT ON OVERALL SLEEP STRUCTURE. THESE PREDICTIONS WILL THEN BE EXPERIMENTALLY TESTED USING CRISPR-SACAS9 TECHNOLOGIES IN VIVO, THE RESULTS OF WHICH WILL THEN FURTHER INFORM/REFINE THE COMPUTATIONAL MODEL (AIM 3). THE END GOAL BEING A DETAILED THEORY / BIOPHYSICAL EXPLANATION FOR THE IMPACT OF AB ACCUMULATION ON HCRT NEURON ACTIVITY AND THEIR ROLE IN SLEEP ARCHITECTURE.

Posted 4/10/24, 12:00 AM